ストックスクリーナーアプリを入手
11.45
1.46%
-0.17
アフターアワーズ：
11.45
Third Harmonic Bio Inc (THRD) 最新ニュース
(THRD) Technical Pivots with Risk Controls - Stock Traders Daily
RA Capital Management Reduces Stake in Third Harmonic Bio Inc - GuruFocus.com
Significant Stake Increase by T. Rowe Price in Third Harmonic Bi - GuruFocus.com
Vertiv Rises 13% in a Month: Time for Investors to Buy the Stock? - MSN
Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade - Yahoo Finance
Shiba Inu (SHIB) Price Rises 53% but Hits Rejection at Key Ascending Resistance Level - MSN
Third Harmonic Bio Reports Q3 2024 Financial Results - TipRanks
Third Harmonic Bio Inc (THRD) Quarterly 10-Q Report - Quartzy
Third Harmonic Bio (THRD) to Present at Major Stifel, Jefferies Healthcare Conferences | THRD Stock News - StockTitan
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Third Harmonic Flat on Q3 Results - Baystreet.ca
Third Harmonic Bio Announces Third Quarter 2024 Financial Results - The Manila Times
Third Harmonic Bio Reports $296M Cash Position, Phase 1 Trial Progress Despite Wider Q3 Loss | THRD Stock News - StockTitan
An RNAi renaissance is creating a new generation of startups - BioPharma Dive
(THRD) Technical Data - Stock Traders Daily
Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Third Harmonic Bio's chief medical officer sells $40,095 in stock - Investing.com
A new biotech, built around protein design, springs from David Baker’s lab - BioPharma Dive
Down -18.64% in 4 Weeks, Here's Why Philips (PHG) Looks Ripe for a Turnaround - MSN
Where are the Opportunities in (THRD) - Stock Traders Daily
Revvity Earnings Preview: What to Expect - MSN
Forbion follows string of startup exits with $2.2B fundraise - BioPharma Dive
(THRD) Trading Signals - Stock Traders Daily
Upstream prices $255M IPO in bid to challenge Amgen, AstraZeneca asthma drug - BioPharma Dive
Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive
Third Harmonic Bio: Nothing Stands Out (NASDAQ:THRD) - Seeking Alpha
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney - BioPharma Dive
How To Trade (THRD) - Stock Traders Daily
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise By Investing.com - Investing.com South Africa
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com
WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India
Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa
Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia
Third harmonic bio executive sells over $140k in stock - Investing.com
Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World
Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily
23andMe faces Nasdaq delisting - MSN
Independent directors resign from 23andMe board after opposing move to privatize - Washington Times
23andMe Stock Falls as All Board Members Resign - Barron's
Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins
Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle
ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire
23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24
23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24
Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Can the Fed’s rate cut change biotech’s ‘new normal’? - BioPharma Dive
Hex And PulseChain Founder Richard Heart In Hot Water With Finnish Authorities - Cryptonews
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki - The Wall Street Journal
Crypto Influencer Richard Heart Investigated for Tax Evasion - Crypto Times
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private - New York Post
Check Out Hyliion Holdings Corporation (HYLN)’s Trade Data Rather Than the Analysts’ Views - SETE News
A Look at Harmonic, Inc. (HLIT) Shares in the Recent Past Indicates Growth - SETE News
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):